<DOC>
	<DOCNO>NCT02853006</DOCNO>
	<brief_summary>The diagnosis lung cancer first cause cancer death man woman . It require invasive procedure ( least endoscopy , transthoracic puncture , surgery ) . This study set innovative test lung cancer prognosis , base biopsy surgical material : LungCancerTest , creation start-up progress . The main goal study approve diagnostic value molecular signature 26 gene ( LungCancerTest ) reveal blood respiratory fluid among patient lung cancer .</brief_summary>
	<brief_title>Study Fluids Associated Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Inclusion Criterias : Patients lung cancer stage 12 , lung cancer histology kind eligible surgery ( Group 1 ) . Patients lung cancer stage 34 ( adenocarcinoma squamous ) receive classical target chemotherapy genetic anomaly ( Group 2 ) . Control patient : carrier noncancerous radiological anomaly : benign nodule , cicatricial lesion , infectious inflammatory , pair two group age , sex tobacco ( Group 3 ) . Adults patient : 18 year . Persons affiliate national social security . Free sign consent . Exclusion Criterias : Persons refer article L11215 L11218 CSP ( protected people ) : pregnants , parturients breastfeed woman , person deprive liberty judicial administrative decision , person legal protection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cancer lung</keyword>
	<keyword>Fluids</keyword>
	<keyword>LungCancerTest</keyword>
	<keyword>radiological anomaly</keyword>
	<keyword>non-cancerous</keyword>
	<keyword>carrier</keyword>
	<keyword>Patient reference</keyword>
</DOC>